18+ Adults only. We do not sell to anyone under 18. Research compounds are supplied for research use only.
A woman on a sofa holding a pen injector

Slimming injections in South Africa: what they are and whether they work

“Slimming injection” is the phrase most South Africans type when they are curious about the new wave of weight-loss jabs. It covers a lot of ground, from prescription medicines with large trials behind them to products with almost no evidence at all. Here is what they are, whether they work, what the side effects are and what happens when you stop.

Slimming injections in 60 seconds

  • Most modern slimming injections are GLP-1 compounds such as semaglutide and tirzepatide. They are taken once a week and mainly reduce appetite.
  • In the large trials they produced average weight loss of roughly 15 to 21 percent of body weight, against 2 to 3 percent on placebo.
  • The side effects are mostly gut related: nausea, diarrhoea, vomiting and constipation.
  • When treatment stopped in one trial, people regained about two thirds of the weight they had lost within a year.

What people mean by slimming injections

The term is used loosely, so it helps to separate the groups. The first and by far the best studied is the GLP-1 family: semaglutide, tirzepatide and, still in trials, retatrutide. These copy gut hormones that signal fullness to the brain. The second group is the so-called lipotropic or “fat dissolving” shots, usually vitamin or amino acid mixes sold in aesthetic clinics. We are not aware of good trial evidence that these cause meaningful weight loss, so ask for the data before paying for them.

The rest of this guide is about the GLP-1 group, because that is where the evidence is. For the molecules themselves, see our guides on GLP-1 compounds and brand names versus molecules.

How they work

GLP-1 is a hormone released from the gut after eating. It tells the brain you are full, slows the emptying of the stomach and helps the body handle glucose. The injections mimic it for much longer than the natural hormone lasts. Tirzepatide also copies a second gut hormone, GIP, and retatrutide adds a third, glucagon. The practical effect is that eating less stops feeling like a daily fight.

Do they work?

Yes, and the size of the effect is the reason they are everywhere. In STEP 1, adults given semaglutide lost an average of 14.9 percent of their body weight over 68 weeks, compared with 2.4 percent on placebo. In SURMOUNT-1, tirzepatide produced average losses of 15.0, 19.5 and 20.9 percent at its three doses over 72 weeks, against 3.1 percent on placebo. Both trials paired the drug with diet and activity advice.

Injection or tablet?

Tablets exist too. In the OASIS 1 trial, a once-daily 50 mg semaglutide tablet produced an average loss of 15.1 percent at 68 weeks, close to the injectable semaglutide result in STEP 1. The tablet has to be taken in a specific way and at a higher dose than the injection, and the injectable tirzepatide trials show the largest effects so far. Which one suits a person is a conversation for a doctor.

Side effects

The common side effects are nausea, diarrhoea, vomiting and constipation, which were more frequent than on placebo in the trials and tended to be worst while the dose was being stepped up. That gradual increase is why these medicines are started low, as we explain in why GLP-1 doses start low. Our general guide to peptide side effects covers what to watch for. Anyone with a history of pancreatitis, gallbladder disease or thyroid cancer in the family needs medical advice before considering any of them.

What happens when you stop

This is the part that gets left out of the adverts. In the STEP 1 extension, people who stopped semaglutide regained 11.6 percentage points of the weight they had lost within a year, about two thirds of it, and the improvements in blood pressure and blood sugar drifted back towards where they started. The authors concluded that obesity is chronic and that ongoing treatment is needed to keep the benefit. Anyone planning to use one should think about the long term, not just the first few months.

Who the trials actually enrolled

The headline numbers describe a specific group: adults with obesity, or with overweight plus at least one weight-related condition, and without diabetes. If your starting point is a few kilograms above a comfortable weight, those averages do not describe you, and the balance of benefit and risk is different. It is also worth remembering that the placebo groups lost 2 to 3 percent. That is not nothing, and it came from the diet and activity advice every participant received alongside the injection.

How fast the weight comes off

Not in weeks. In the retatrutide phase 2 trial, average loss at the highest dose was 17.5 percent at 24 weeks and 24.2 percent at 48 weeks, so the curve keeps building for most of a year. The semaglutide and tirzepatide trials ran 68 to 72 weeks for the same reason. Anyone promising a large loss in a month is describing something these trials did not show.

Beyond the scale

The SELECT trial followed 17,604 adults with established cardiovascular disease and overweight or obesity, without diabetes, for an average of almost 40 months. A major cardiovascular event (cardiovascular death, non-fatal heart attack or non-fatal stroke) happened in 6.5 percent of those on semaglutide and 8.0 percent on placebo, a hazard ratio of 0.80. That result applies to people who already had heart disease, so it should not be stretched to everyone, and the trial was funded by the manufacturer. It does show that the benefit may extend beyond the number on the scale.

The muscle question

Weight lost on any of these medicines is not all fat. A meaningful share can be lean mass, which is why protein intake and resistance training matter more, not less, while the weight is coming off. Our guides on losing fat without losing muscle and measuring body composition cover how to keep an eye on it.

Questions to take to a doctor

  • Am I a candidate, given my BMI, health conditions and any other medicines I take?
  • Which baseline blood tests should be done first?
  • What is the plan for the first few months, including how the dose is stepped up?
  • What do I do if nausea or other side effects become a problem?
  • What is the plan for protein, strength training and keeping muscle?
  • What is the plan if or when I stop, given how much weight tends to return?

Red flags in an online offer

  • No questions about your health or other medicines.
  • A product described only as a “slimming jab” with no compound name and strength.
  • No batch number or certificate of analysis you can ask to see.
  • A price far below everyone else, or a claim of guaranteed results.
  • No information on cold storage and shipping, or no way to contact a real business.

Where this leaves you in South Africa

Semaglutide and tirzepatide sold under brand names are prescription medicines. The compounds we supply are sold for research use only and are not registered medicines, so they are not a substitute for a doctor-led plan. Prices vary by product, strength and supplier, so compare per milligram rather than per box.

Questions people ask

What are slimming injections?

Mostly GLP-1 compounds such as semaglutide and tirzepatide, taken once a week. They copy gut hormones that signal fullness and mainly reduce appetite.

Do slimming injections work?

In large trials, yes. Average weight loss was roughly 15 to 21 percent of body weight, compared with 2 to 3 percent on placebo, alongside diet and activity advice.

Are slimming injections safe?

The common side effects are nausea, diarrhoea, vomiting and constipation. They are not suitable for everyone, so speak to a doctor first, especially if you have pancreatitis, gallbladder disease or a family history of thyroid cancer.

Is a weight loss injection better than a tablet?

Oral semaglutide at 50 mg produced about the same average loss as the injection in separate trials, and injectable tirzepatide has shown larger effects so far. A doctor can help choose.

What happens if I stop?

In the STEP 1 extension, people regained about two thirds of the weight they had lost within a year of stopping semaglutide.

How fast do you lose weight on slimming injections?

Gradually. In the trials, weight kept falling for most of a year. In the retatrutide phase 2 trial, average loss at the top dose was 17.5 percent at 24 weeks and 24.2 percent at 48 weeks.

Do slimming injections help the heart?

In the SELECT trial of adults who already had heart disease and overweight or obesity, semaglutide lowered the rate of major cardiovascular events from 8.0 to 6.5 percent compared with placebo. That does not automatically apply to people without heart disease.

Sources

  1. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021;384:989-1002.
  2. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022;387:205-216.
  3. Knop FK, et al. Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1). Lancet 2023;402:705-719.
  4. Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab 2022;24:1553-1564.
  5. Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT). N Engl J Med 2023;389:2221-2232.
  6. Jastreboff AM, et al. Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial. N Engl J Med 2023;389:514-526.

This article is for educational purposes only and is not medical advice. The compounds we supply are sold for research use only and are not registered medicines. Our guide to whether peptides are legal in South Africa explains what that means.

Wondering how dose changes the result? Read GLP-1 dosing: what the research says. For the full goal guide, see peptides for weight loss. Comparing them with supplements? Read fat burners vs peptides for weight loss.